 | Kymera Therapeutics, Inc. | |||
| NGM : KYMR || Location: United States | ||||
$33.76-0.17 (-0.5%) |
0.43 M | 33.17 - 34.41 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 9.062 M |
| March 15, 2024 | 8.327 M |
| Feb. 29, 2024 | 8.248 M |
| Feb. 15, 2024 | 8.397 M |
| Jan. 31, 2024 | 8.258 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.41 | -0.25 | 39.48% |
| 09/30/2023 | -0.65 | -0.90 | -37.57% |
| 06/30/2023 | -0.65 | -0.67 | -3.17% |
| 03/31/2023 | -0.69 | -0.70 | -1.30% |
| 12/31/2022 | -0.65 | -0.60 | 7.09% |
KYMR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 61.112M | Shares Float | 40.078M |
| Short Float | 9.062M | Market Cap | 2063.14M |
| Institution ownership | 0.00% | Insider ownership | 1.380% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.52 | Forward EPS | -3.23 |